HopeStage
Back to all studies
RecruitingNCT05842330

OROS-methylphenidate or placebo for detained people with ADHD

About this titleRead the official source — NCT05842330
Medication studyAges 18–65Switzerland
The study in practice

Understand this study

Who could participate?

This study is for people with ADHD. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

What will I do during this study?

During detention, participants are randomly assigned to three months of methylphenidate or placebo (an inactive comparison treatment). The dose is adjusted according to response and side effects; treatment is checked weekly during the first month, then monthly. Everyone also receives a cognitive behavioural education program in detention and therapy after release. Side effects are monitored daily in detention and every two weeks after release, with follow-up on behaviour for one year.

Listed locations
GenevaSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: January 1, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
150
Sponsor
Stéphanie Baggio
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Switzerland
Age range
From 18 Years to 65 Years
Official registry ID
NCT05842330
Official title
Show the full official title

Benefits of In-prison OROS-methylphenidate vs. Placebo Treatment in Detained People With Attention-deficit/Hyperactivity Disorder: A Randomized Controlled Trial

Recruitment & locations

Currently recruiting

Geneva

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Stéphanie Baggio.

Does this study involve medication?

Yes. The study involves medication, including Concerta and Placebo.

Who can participate?

This study is for people with ADHD. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies